Angiodynamics (ANGO) Short-term Investments (2011 - 2018)

Angiodynamics has reported Short-term Investments for 8 years, with the latest figure at $1.3 million in Q4 2018.

• For the quarter ending Q4 2018, Short-term Investments rose 7.14% year-over-year to $1.3 million; the trailing twelve-month figure through Nov 2018 stood at $1.3 million (up 7.14% YoY), and the FY2018 full-year result was $1.3 million, up 8.4% from the prior year.
• Short-term Investments for Q4 2018 stood at $1.3 million, roughly flat from $1.3 million in the prior quarter.
• The five-year high for Short-term Investments was $1.8 million in Q2 2014, with the low at $1.2 million in Q4 2016.
• Historically, Short-term Investments has averaged $1.5 million across 5 years, with a median of $1.6 million in 2015.
• Annual changes were most pronounced in 2017 — Short-term Investments declined 27.79% — and 2018, when it grew 11.11%.
• Angiodynamics' Short-term Investments stood at $1.7 million in 2014, then decreased by 3.47% to $1.6 million in 2015, then declined by 26.6% to $1.2 million in 2016, then grew by 4.74% to $1.3 million in 2017, then increased by 7.14% to $1.3 million in 2018.
• The last three Short-term Investments figures came in at $1.3 million (Q4 2018), $1.3 million (Q3 2018), and $1.3 million (Q2 2018), per Business Quant data.